Average Co-Inventor Count = 4.59
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Eli Lilly and Company (22 from 4,442 patents)
2. Agouron Pharmaceuticals, Inc. (9 from 174 patents)
31 patents:
1. 9776992 - 1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers
2. 8217032 - Selective estrogen receptor modulators for the treatment of vasomotor symptoms
3. 8148387 - AKT and P70 S6 kinase inhibitors
4. 7863310 - Kinase inhibitors
5. 7745438 - 3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors
6. 7585885 - Pyrrolidine derivatives useful as BACE inhibitors
7. 7585977 - Selective estrogen receptor modulators containing a phenylsulfonyl group
8. 7399867 - Selective estrogen receptor modulators containing a phenylsulfonyl group
9. 7320995 - Benzimidazoles and benzothiazoles as inhibitors of map kinase
10. 6992097 - Growth hormone secretagogues
11. 6939946 - Ring modified cyclic peptide analogs
12. 6900353 - Cyclopentyl sulfonamide derivatives
13. 6703425 - Sulfonamide derivatives
14. 6693199 - Method of making HIV protease inhibitors
15. 6653281 - Ring modified cyclic peptide analogs